$XBIT 4/A SEC Filings

Filed On	Filing
27 Apr 2021	Form 4/A: Simard John, Director Granted 0 Stock Options
19 Mar 2020	Form 4/A: Mckenzie W Thorpe, Director Returned 1,515,587 shares to the issuer ($45.5M)
19 Mar 2020	Form 4/A: Simard John, Director Returned 2,103,894 shares to the issuer ($63.1M)
19 Mar 2020	Form 4/A: Waldin Jan-Paul, Director Returned 99,757 shares to the issuer ($2.99M)
05 Mar 2020	Form 4/A: Gut Thomas, 10% owner Returned 1,949,929 shares to the issuer ($58.5M)
19 Feb 2020	Form 4/A: Gut Thomas, 10% owner Returned 1,947,584 shares to the issuer ($58.4M)
04 Mar 2019	Form 4/A: Mckenzie W Thorpe, Director Bought 24,838 shares ($146K) · Bought 18,636 shares ($94.6K) · Bought 1,364 shares ($6.71K)
21 Jun 2018	Form 4/A: Han Queena, VP Finance & HR Granted 40,000 Stock Option
23 Jun 2017	Form 4/A: Shivaswamy Sushma, VP Research and Development Acquired 50,000 Stock Option (Option Exercise/Conversion) ($212K)
23 Jun 2017	Form 4/A: Stecher Michael, Medical Director Acquired 50,000 Stock Option (Option Exercise/Conversion) ($212K)
23 Jun 2017	Form 4/A: Mckenzie W Thorpe, Director Acquired 50,000 Stock Option (Option Exercise/Conversion) ($212K)
23 Jun 2017	Form 4/A: Simard John, Director Acquired 75,000 Stock Option (Option Exercise/Conversion) ($318K)
23 Jun 2017	Form 4/A: Han Queena, VP Finance & HR Acquired 30,000 Stock Option (Option Exercise/Conversion) ($127K)
13 Mar 2017	Form 4/A: Mckenzie W Thorpe, Director Holds 5,750 shares of Common Stock
23 Dec 2015	Form 4/A: Han Queena, VP Finance / HR Exercised 10,000 Stock Option · Received 10,000 shares by exercise or conversion ($7.2K) · Sold 10,000 shares ($106K) · 4 more
19 Nov 2015	Form 4/A: Stecher Michael, Medical Director Received 1,800 shares by exercise or conversion ($9K) · Sold 1,800 shares ($25.2K)

Comments